5-79668946-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001114394.3(TENT2):c.1126G>A(p.Val376Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,708 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001114394.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TENT2 | NM_001114394.3 | c.1126G>A | p.Val376Ile | missense_variant | 12/15 | ENST00000453514.6 | NP_001107866.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TENT2 | ENST00000453514.6 | c.1126G>A | p.Val376Ile | missense_variant | 12/15 | 5 | NM_001114394.3 | ENSP00000397563 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152062Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251370Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135866
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1461528Hom.: 0 Cov.: 31 AF XY: 0.0000509 AC XY: 37AN XY: 727072
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152180Hom.: 1 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2022 | The c.1126G>A (p.V376I) alteration is located in exon 12 (coding exon 11) of the PAPD4 gene. This alteration results from a G to A substitution at nucleotide position 1126, causing the valine (V) at amino acid position 376 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at